These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15686480)

  • 1. Attenuated microglial activation mediates tolerance to the neurotoxic effects of methamphetamine.
    Thomas DM; Kuhn DM
    J Neurochem; 2005 Feb; 92(4):790-7. PubMed ID: 15686480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation.
    Thomas DM; Walker PD; Benjamins JA; Geddes TJ; Kuhn DM
    J Pharmacol Exp Ther; 2004 Oct; 311(1):1-7. PubMed ID: 15163680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MK-801 and dextromethorphan block microglial activation and protect against methamphetamine-induced neurotoxicity.
    Thomas DM; Kuhn DM
    Brain Res; 2005 Jul; 1050(1-2):190-8. PubMed ID: 15987631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microglial activation precedes dopamine terminal pathology in methamphetamine-induced neurotoxicity.
    LaVoie MJ; Card JP; Hastings TG
    Exp Neurol; 2004 May; 187(1):47-57. PubMed ID: 15081587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in vesicular dopamine uptake contribute to tolerance to the neurotoxic effects of methamphetamine.
    Johnson-Davis KL; Truong JG; Fleckenstein AE; Wilkins DG
    J Pharmacol Exp Ther; 2004 May; 309(2):578-86. PubMed ID: 14747615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-alpha.
    Sriram K; Miller DB; O'Callaghan JP
    J Neurochem; 2006 Feb; 96(3):706-18. PubMed ID: 16405514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine quinones activate microglia and induce a neurotoxic gene expression profile: relationship to methamphetamine-induced nerve ending damage.
    Kuhn DM; Francescutti-Verbeem DM; Thomas DM
    Ann N Y Acad Sci; 2006 Aug; 1074():31-41. PubMed ID: 17105901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of the radical scavenger edaravone against methamphetamine-induced dopaminergic neurotoxicity in mouse striatum.
    Kawasaki T; Ishihara K; Ago Y; Nakamura S; Itoh S; Baba A; Matsuda T
    Eur J Pharmacol; 2006 Aug; 542(1-3):92-9. PubMed ID: 16784740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurotoxic-related changes in tyrosine hydroxylase, microglia, myelin, and the blood-brain barrier in the caudate-putamen from acute methamphetamine exposure.
    Bowyer JF; Robinson B; Ali S; Schmued LC
    Synapse; 2008 Mar; 62(3):193-204. PubMed ID: 18081184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microglial activation is a pharmacologically specific marker for the neurotoxic amphetamines.
    Thomas DM; Dowgiert J; Geddes TJ; Francescutti-Verbeem D; Liu X; Kuhn DM
    Neurosci Lett; 2004 Sep; 367(3):349-54. PubMed ID: 15337264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining "neuroinflammation".
    O'Callaghan JP; Sriram K; Miller DB
    Ann N Y Acad Sci; 2008 Oct; 1139():318-30. PubMed ID: 18991877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic stress augments the long-term and acute effects of methamphetamine.
    Matuszewich L; Yamamoto BK
    Neuroscience; 2004; 124(3):637-46. PubMed ID: 14980734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclooxygenase-2 is an obligatory factor in methamphetamine-induced neurotoxicity.
    Thomas DM; Kuhn DM
    J Pharmacol Exp Ther; 2005 May; 313(2):870-6. PubMed ID: 15718289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender-dependent enhanced adult neurotoxic response to methamphetamine following fetal exposure to the drug.
    Heller A; Bubula N; Lew R; Heller B; Won L
    J Pharmacol Exp Ther; 2001 Aug; 298(2):769-79. PubMed ID: 11454941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutual enhancement of central neurotoxicity induced by ketamine followed by methamphetamine.
    Ke JJ; Chen HI; Jen CJ; Kuo YM; Cherng CG; Tsai YP; Ho MC; Tsai CW; Yu L
    Toxicol Appl Pharmacol; 2008 Mar; 227(2):239-47. PubMed ID: 18076959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of tolerance to methamphetamine-induced monoamine deficits.
    Danaceau JP; Deering CE; Day JE; Smeal SJ; Johnson-Davis KL; Fleckenstein AE; Wilkins DG
    Eur J Pharmacol; 2007 Mar; 559(1):46-54. PubMed ID: 17239369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcitriol protects against the dopamine- and serotonin-depleting effects of neurotoxic doses of methamphetamine.
    Cass WA; Smith MP; Peters LE
    Ann N Y Acad Sci; 2006 Aug; 1074():261-71. PubMed ID: 17105922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of dopamine D1 and D2 receptor antagonists with D-methamphetamine-induced hyperthermia and striatal dopamine and serotonin reductions.
    Broening HW; Morford LL; Vorhees CV
    Synapse; 2005 May; 56(2):84-93. PubMed ID: 15714503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methamphetamine-induced selective dopaminergic neurotoxicity is accompanied by an increase in striatal nitrate in the mouse.
    Anderson KL; Itzhak Y
    Ann N Y Acad Sci; 2006 Aug; 1074():225-33. PubMed ID: 17105919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotoxic regimen of methamphetamine produces evidence of behavioral sensitization in the rat.
    Wallace TL; Gudelsky GA; Vorhees CV
    Synapse; 2001 Jan; 39(1):1-7. PubMed ID: 11071703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.